Audrey Andrews

Authored Items
Suboptimal Dosing of Filgrastim Is Acceptable for Treatment of Chemotherapy- Induced Neutropenia
Audrey Andrews
TOP - August 2018, Vol 11, No 2 in Side-Effects Management
Suboptimal Dosing of Filgrastim is Acceptable for Treatment of Chemotherapy-Induced Neutropenia
Audrey Andrews
TON - May 2018, Vol 11, No 2 in Side-Effects Management
Project Aims to Prevent Future Infusion-Related Reactions
Audrey Andrews
TOP - May 2017, Vol 10, No 2 in NCCN News
Pharmacy-Led Intervention Improved Tyrosine Kinase Inhibitor Adherence and Monitoring
Audrey Andrews
TOP - May 2017, Vol 10, No 2 in NCCN News
Noncompliance with Granulocyte Colony-Stimulating Factor Guidelines Has Consequences
Audrey Andrews
TOP - May 2017, Vol 10, No 2 in NCCN News
New Survey Reveals How Pharmacies Manage Verification Processes
Audrey Andrews
TOP - November 2016, Vol 9, No 4 in Best Practices
Dose Modifications of Lenalidomide Lead to Good Outcomes in Myelodysplastic Syndrome
Audrey Andrews
TOP - November 2016, Vol 9, No 4 in Hematologic Cancers
Palliative Care Specialists Want More Involvement
Audrey Andrews
TON July 2016 Vol 9 No 4 in Conference Correspondent
Managing Dermatologic Toxicities
Audrey Andrews
TOP November 2015 Vol 8 No 4 in Conference Correspondent
Managing Dermatologic Toxicities
Audrey Andrews
TOP Web Exclusives in Conference Correspondent, Online Only
Managing Dermatologic Toxicities
Audrey Andrews
TON May 2015 Vol 8 No 3 in Best Practices
Maximizing Efficacy in the Infusion Unit: Making Patients and Nurses Happy
Audrey Andrews
TON May 2015 Vol 8 No 3 in Best Practices
Sorafenib Effective in Metastatic Differentiated Thyroid Cancer
Audrey Andrews
TON - August 2013 Vol 6 No 7 in Rare Cancers
NCCN Updates Its Clinical Practice Guidelines
Audrey Andrews
TON - July 2013 Vol 6 No 6 in Best Practices
The Changing Oncology Landscape: Evolution or Revolution?
Audrey Andrews
TON - July 2013 Vol 6 No 6 in Conference Correspondent
Distress Screening Should Be Integrated Into Routine Cancer Care
Audrey Andrews
TON - April 2013, Vol 6, No 3 in Conference Correspondent
Enhancing Communication in the Advanced-Disease Setting
Audrey Andrews
TON - April 2013, Vol 6, No 3 in Conference Correspondent
Home-Based TPN of Little Benefit in Terminally Ill Patients With GI Cancer
Audrey Andrews, Caroline Helwick
TON - March 2013, Vol 6, No 2 in Supportive Care, Supportive Care
Evidence Lacking for Eliminating Prophylactic Platelet Transfusions
Audrey Andrews
TON - March 2013, Vol 6, No 2 in Supportive Care
Peripheral Arterial Disease Seen With Nilotinib
Audrey Andrews
TON - March 2013, Vol 6, No 2 in Supportive Care
Peripheral Arterial Disease Seen With Nilotinib
Audrey Andrews
TOP - February 2013 VOL 6, NO 1 in Supportive Care
Crizotinib Is Just the Beginning
Audrey Andrews
TOP - December 2012 VOL 5, NO 8
No Increase in Leukemia or Myelodysplastic Syndrome With Adjuvant Chemotherapy for Breast Cancer
Audrey Andrews
TON - November 2012, Vol 5, No 10 in Breast Cancer
Crizotinib Superior to Chemotherapy in First Head-to-Head Comparison
Audrey Andrews
TON - November 2012, Vol 5, No 10 in Lung Cancer
Regional Lymph Node Irradiation Indicated for Early Breast Cancer
Audrey Andrews
TON - October 2011 Vol 4 No 7 in Breast Cancer
Prolonged Treatment with Imatinib Recommended for High-Risk GIST
Audrey Andrews
TON - September 2011 Vol 4, No 6 in Conference Correspondent
Exemestane: A Promising New Option for Primary Prevention of Breast Cancer
Audrey Andrews
Online First in Conference Correspondent
Bevacizumab in Ovarian Cancer: More Support for Maintenance
Audrey Andrews
Online First in Conference Correspondent
Novel Agents Improve Survival in Metastatic Melanoma
Audrey Andrews
Online First in Conference Correspondent
PARP Inhibitor Prolongs Progression-Free Survival in Ovarian Cancer
Audrey Andrews
Online First in Conference Correspondent
NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia
Audrey Andrews
Online First in Supportive Care
Hepatitis B Screening and Chemotherapy
Audrey Andrews
TON - June 2011, Vol 4, No 4 in Supportive Care
NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia
Audrey Andrews
TON - Daily in Prevention
Hepatitis B Screening and Chemotherapy
Audrey Andrews
TON - Daily
NCCN Updates Treatment Guidelines
Audrey Andrews
TON - March/April 2011, VOL 4, NO 2 in Guidelines
Last modified: December 11, 2015